Erik Allman is an experienced scientist currently serving as an Associate Director at AstraZeneca, specializing in preclinical and clinical metabolomics. They have expertise in metabolomics, systems biology, molecular biology, and infectious disease research, with a focus on high-throughput screening and method development. Previously, Erik worked as a post-doctoral fellow at Janssen Pharmaceuticals, where they explored host-microbiome lipid crosstalk using advanced mass spectrometry techniques. Erik completed their PhD and MS in Pharmacology at the University of Rochester School of Medicine and Dentistry, where they investigated metabolic pathways in malaria. Their early research included undergraduate work in biochemistry that contributed to advancements in enzyme activity detection.
This person is not in the org chart
This person is not in any teams
This person is not in any offices